肥胖流行:其对全关节置换术的影响被低估了吗?全国趋势分析
该研究利用1998年至2011年美国全国住院患者样本,通过数学方程估算初次、翻修和感染性全关节置换术(TJA)患者中肥胖的患病率。结果显示,初次全髋关节置换术(THA)、全膝关节置换术(TKA)、翻修THA/TKA及感染性THA/TKA患者中肥胖患病率均逐年上升(每年增加0.65%至1.05%,p<0.001)。作者认为肥胖流行似乎与TJA后翻修和感染趋势相关,未来翻修和感染负担可能增加。
要点
- 初次THA患者肥胖患病率从1998年39%升至2011年52%,每年增加1.05%(95%CI 0.95%-1.15%,p<0.001)。
- 初次TKA患者肥胖患病率从1998年57%升至2011年70%,每年增加0.97%(95%CI 0.87%-1.07%,p<0.001)。
- 感染性THA和TKA患者肥胖患病率分别从69%和76%升至79%和85%,每年增加0.80%和0.65%(p<0.001)。
核心结论
- 在美国,接受初次、翻修和感染性TJA的患者中肥胖患病率均增加。
- 肥胖流行似乎与TJA后翻修和感染的增长趋势相关。
- 随着肥胖率预计进一步增长,与肥胖相关的翻修和感染负担未来可能增加。
研究设计与样本
- 预后研究,证据等级为Level II。
- 从全国住院患者样本获取1998年至2011年初次、翻修和感染性THA与TKA的年度手术量。
- 使用数学方程,根据相对风险和全国肥胖患病率估算肥胖患病率;全国肥胖患病率来自公共卫生来源,相对风险估计来自已发表的荟萃分析和基于人群的研究。
- 年度肥胖患病率通过将每年肥胖的初次/翻修/感染手术数除以当年相应手术总数获得。
- 使用线性回归分析肥胖患病率的年度变化。
主要发现
- 初次THA:肥胖患病率1998年为154337例中60264例(39%),2011年为305755例中160241例(52%),每年增加1.05%(95%CI 0.95%-1.15%,p<0.001)。
- 初次TKA:肥胖患病率1998年为251309例中143681例(57%),2011年为644243例中448712例(70%),每年增加0.97%(95%CI 0.87%-1.07%,p<0.001)。
- 翻修THA:肥胖患病率1998年为34139例中16322例(48%),2011年为54453例中33304例(61%),每年增加1.04%(95%CI 0.94%-1.15%,p<0.001)。
- 翻修TKA:肥胖患病率1998年为26539例中16837例(63%),2011年为69632例中52151例(75%),每年增加0.89%(95%CI 0.79%-0.99%,p<0.001)。
- 感染性THA:肥胖患病率1998年为3018例中2068例(69%),2011年为8687例中6856例(79%),每年增加0.80%(95%CI 0.71%-0.89%,p<0.001);感染性TKA:肥胖患病率1998年为4684例中3563例(76%),2011年为16774例中14178例(85%),每年增加0.65%(95%CI 0.57%-0.73%,p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is a well-established risk factor for total joint arthroplasty (TJA) and a number of complications including prosthetic joint infection. The annual changes in the prevalence of obesity among primary, revision, and infected TJA has not been studied at a national level. Given the higher costs of complications of TJA, it is important to understand the association of obesity with the annual trends of revision and infected TJA. QUESTIONS/PURPOSES: (1) Is the prevalence of obesity increasing among patients undergoing THA/TKA? (2) Is the prevalence of obesity increasing among patients undergoing revision THA/TKA? (3) Is the prevalence of obesity increasing among patients with infected THA/TKA? METHODS: Annual volumes of primary, revision, and infected THA and TKA from 1998 to 2011 were obtained from the Nationwide Inpatient Sample. Using mathematical equations, the prevalence of obesity was estimated from relative risks and national obesity prevalence. National obesity prevalence was obtained from public health sources and the relative risk estimates were obtained from previously published meta-analyses and population-based studies. Annual prevalence of obesity was obtained by dividing the number of obese primary/revision/infected procedures in each year by the total number of corresponding procedures in that year. Annual changes in the prevalence of obesity were analyzed using linear regression. RESULTS: The prevalence of obesity is increasing among patients undergoing THA (1998: 60,264 of 154,337 [39%], 2011: 160,241 of 305,755 [52%], increase of 1.05%/year [confidence interval {CI}, 0.95%-1.15%], p < 0.001) and TKA (1998: 143,681 of 251,309 [57%], 2011: 448,712 of 644,243 [70%], increase of 0.97%/year [CI, 0.87%-1.07%], p < 0.001). There was an increasing prevalence of obesity with THA revisions (1998: 16,322 of 34,139 [48%], 2011: 33,304 of 54,453 [61%], increase of 1.04%/year [CI, 0.94%-1.15%], p < 0.001) and in TKA revisions (1998: 16,837 of 26,539 [63%], 2011: 52,151 of 69,632 [75%], increase of 0.89%/year [CI, 0.79%-0.99%], p < 0.001). There was an increasing prevalence of obesity with THA infections (1998: 2068 of 3018 [69%], 2011: 6856 of 8687 [79%], increase of 0.80%/year [CI, 0.71%-0.89%], p < 0.001) and in TKA infections (1998: 3563 of 4684 [76%], 2011: 14,178 of 16,774 [85%], increase of 0.65%/year [CI, 0.57%-0.73%], p < 0.001). CONCLUSIONS: The prevalence of obesity has increased in patients undergoing primary, revision, and infected TJA in United States. The obesity epidemic appears to be related to the growing trends of revision and infection after TJA. With the obesity rates expected to grow further, the revision and infection burden associated with obesity may increase in the future. LEVEL OF EVIDENCE: Level II, prognostic study.
引用
- George J, Klika AK, Navale SM, et al. Obesity Epidemic: Is Its Impact on Total Joint Arthroplasty Underestimated? An Analysis of National Trends. Clin Orthop Relat Res. 2017. PMID: 28054327. doi:10.1007/s11999-016-5222-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。